Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7112)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2013 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Yang FR, Fang BW, Lou JS. Effects of Fufang Biejia Ruangan Pills on hepatic fibrosis |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i32/5326.htm |
| Number | Citing Articles |
| 1 |
Shu-Ping You, Long Ma, Jun Zhao, Shi-Lei Zhang, Tao Liu. Phenylethanol Glycosides from Cistanche tubulosa Suppress Hepatic Stellate Cell Activation and Block the Conduction of Signaling Pathways in TGF-β1/smad as Potential Anti-Hepatic Fibrosis Agents. Molecules 2016; 21(1): 102 doi: 10.3390/molecules21010102
|
| 2 |
Zhi-Jun Hou, Jing-Hao Zhang, Xin Zhang, Qi-Hua Ling, Chao Zheng, Xiao-Jun Zhu, Zhen-Hua Zhou, Man Li, Xiao-Ni Kong, Xue-Hua Sun, Yue-Qiu Gao, Jian-Jie Chen, Maria G. Miguel. Long‐Term Traditional Chinese Medicine Combined with NA Antiviral Therapy on Cirrhosis Incidence in Chronic Hepatitis B Patients in the Real‐World Setting: A Retrospective Study. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/3826857
|
| 3 |
Baode Shen, Li Deng, Yuan Liu, Ruisheng Li, Chengying Shen, Xiao Liu, Yinchao Li, Hailong Yuan. Effects of novel Fufang Biejia Ruangan Tablets with sheep placenta as substitute for Hominis Placenta on CCl4-induced liver fibrosis. Chinese Herbal Medicines 2022; 14(1): 104 doi: 10.1016/j.chmed.2021.09.013
|
| 4 |
Hui Li. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula. Journal of Ethnopharmacology 2020; 251: 112442 doi: 10.1016/j.jep.2019.112442
|
| 5 |
Yanqiong Zhang, Xia Mao, Wenjia Chen, Xiaodong Guo, Liangxiang Yu, Funeng Jiang, Xiaoyue Wang, Weijie Li, Qiuyan Guo, Taixian Li, Na Lin. A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation. Molecular Therapy - Nucleic Acids 2020; 19: 890 doi: 10.1016/j.omtn.2019.12.023
|
| 6 |
Shao-Ru Chen, Xiu-Ping Chen, Jin-Jian Lu, Ying Wang, Yi-Tao Wang. Potent natural products and herbal medicines for treating liver fibrosis. Chinese Medicine 2015; 10(1) doi: 10.1186/s13020-015-0036-y
|
| 7 |
Ming Hong, Sha Li, Hor Tan, Ning Wang, Sai-Wah Tsao, Yibin Feng. Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects. International Journal of Molecular Sciences 2015; 16(12): 28705 doi: 10.3390/ijms161226126
|
| 8 |
Ting-Ting Jiang, Xiao-Li Liu, Yu-Yong Jiang, Xian-Bo Wang, Zhi-Yun Yang, Guang Chen. Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6652858
|
| 9 |
Hor-Yue Tan, Serban San-Marina, Ning Wang, Ming Hong, Sha Li, Lei Li, Fan Cheung, Xiao-Yan Wen, Yibin Feng, Yoshiji Ohta. Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/4750163
|
| 10 |
Wen-Qing Li, Wen-Hao Liu, Die Qian, Jia Liu, Shi-Qiong Zhou, Lei Zhang, Wei Peng, Li Su, Hong Zhang. Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.962525
|
| 11 |
Xiongqun Peng, Huixiang Yang, Lijian Tao, Jingni Xiao, Ya Zeng, Yueming Shen, Xueke Yu, Fei Zhu, Jiao Qin. Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer. PeerJ 2023; 11: e16060 doi: 10.7717/peerj.16060
|
| 12 |
Youwei Zhao, Lijun Wang, Man Xie, Wei Rao. Progress in the diagnosis and treatment of graft fibrosis after liver transplantation. Portal Hypertension & Cirrhosis 2024; 3(1): 22 doi: 10.1002/poh2.70
|
| 13 |
Lijun Wan, Chungen Hu, Fenfen Wang, Kedong Xu, Fan Li, Bo He, Zhengqiang Wu, Linfei Luo, Zhili Wen. Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46459-4
|
| 14 |
Shihao Zheng, Chengyuan Xue, Size Li, Xiaobin Zao, Xiaoke Li, Qiyao Liu, Xu Cao, Wei Wang, Wenying Qi, Hongbo Du, Peng Zhang, Yongan Ye. Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1381476
|
| 15 |
Qun Zhang, Yu-xin Li, Yao Liu, Yi-xin Hou, Bing-bing Zhu, Yun-yi Huang, Ke Shi, Xian-bo Wang. Effects of Adjuvant Chinese Patent Medicine Therapy on Prevention of Variceal Rebleeding: A Retrospective Cohort Study. Chinese Journal of Integrative Medicine 2021; 27(8): 589 doi: 10.1007/s11655-020-3272-7
|
| 16 |
Guanghua Rong, Yongping Chen, Zujiang Yu, Qin Li, Jingfeng Bi, Lin Tan, Dedong Xiang, Qinghua Shang, Chunliang Lei, Liang Chen, Xiaoyu Hu, Jing Wang, Huabao Liu, Wei Lu, Yan Chen, Zheng Dong, Wenlin Bai, Eric M Yoshida, Nahum Mendez-Sanchez, Ke-Qin Hu, Xingshun Qi, Yongping Yang. Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Infectious Diseases 2022; 225(6): 1091 doi: 10.1093/infdis/jiaa266
|
| 17 |
Xiangbo Meng, Zhengqi Pan, Jiawei Zhao, Quansheng Feng. Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis. Medicine 2022; 101(46): e31664 doi: 10.1097/MD.0000000000031664
|
| 18 |
Qian Zhang, Meng-Meng Shang, Qu-Fei Ling, Xiao-Ping Wu, Chun-Yu Liu. Hepatoprotective effects of loach (Misgurnus anguillicaudatus) lyophilized powder on dimethylnitrosamine-induced liver fibrosis in rats. Archives of Pharmacal Research 2021; 44(8): 1 doi: 10.1007/s12272-014-0445-y
|
| 19 |
Betty Law, Simon Mok, An Wu, Christopher Lam, Margaret Yu, Vincent Wong. New Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of Autophagy. Molecules 2016; 21(3): 359 doi: 10.3390/molecules21030359
|
| 20 |
Shu-Ping You, Jun Zhao, Long Ma, Mukaram Tudimat, Shi-Lei Zhang, Tao Liu. Preventive effects of phenylethanol glycosides from Cistanche tubulosa on bovine serum albumin-induced hepatic fibrosis in rats. DARU Journal of Pharmaceutical Sciences 2015; 23(1) doi: 10.1186/s40199-015-0135-4
|
| 21 |
Yufei Bi, Ke Shi, Jialiang Chen, Xianbo Wang. Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1159222
|
| 22 |
Chun‐xiao Pan, Fan‐rong Wu, Xiao‐yu Wang, Jie Tang, Wen‐fan Gao, Jin‐fang Ge, Fei‐hu Chen. Inhibition of ASICs reduces rat hepatic stellate cells activity and liver fibrosis: An in vitro and in vivo study. Cell Biology International 2014; 38(9): 1003 doi: 10.1002/cbin.10287
|
| 23 |
Xiujie Liu, Jing Su, Yu Shi, Ying Guo, Imran Suheryani, Shicong Zhao, Yulin Deng, Weiwei Meng, Yan Chen, Lili Sun, Rongji Dai. Herbal Formula, Baogan Yihao (BGYH), Prevented Dimethylnitrosamine(DMN)‐Induced Liver Injury in Rats. Drug Development Research 2017; 78(3-4): 155 doi: 10.1002/ddr.21388
|